Search - tctmd.com

Displaying 121 - 140 of 155

Sort: Relevancy | Date

Presentation TCT 2017

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Samir R. Kapadia, Ioanna Kosmidou

November 01, 2017

Presentation TCT 2017

PIONEER AF: Topline Findings and Practice Implications

Presenter: Robert A. Harrington, Evan A. Stein, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger

November 01, 2017

Presentation TCT 2017

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay

November 01, 2017

Presentation TCT 2017

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Presenter: Christopher B. Granger, Horst Sievert, Renu Virmani

October 30, 2017

Presentation CDM 2017

Current Approach of Atrial Fibrillation Management

Presenter: Wilber W. Su

October 06, 2017

Presentation LAA 2017

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

Presenter: Zahid Amin

July 22, 2017

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Presentation TVT 2017

Delayed Cardiac Arrest After On-Pump Transcatheter Valve Trans-septal Mitral Valve-in-Valve Replacement Combined With Alcohol Septal Ablation to Relieve Left Ventricular Outflow Tract Obstruction: A Cautionary Tale

Presenter: Horst Sievert, Robert L. Smith, Hasan Ahmad, MD

June 16, 2017

Presentation TVT 2017

Mitraclip in Systolic Anterior Motion in Patient Not Suitable for Septal Myectomy or Alcohol Ablation

Presenter: Maurice Buchbinder, Patrick M. McCarthy, Paolo Denti

June 15, 2017

Presentation TVT 2017

Advances in Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

Presenter: Tamim Nazif

June 15, 2017

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

Presentation SWVS 2017

Cases: The Good, The Bad and The Ugly

Presenter: Michael J. Reardon

May 07, 2017

Presentation SIF 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presenter: Samir Kapadia

March 09, 2017

Presentation

Apixaban in Patients With Atrial Fibrillation After TAVR

Presenter: J. Seeger

January 03, 2017

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

Presentation TCT 2016

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt

November 01, 2016

Advertisement

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

PIONEER AF: Topline Findings and Practice Implications

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Current Approach of Atrial Fibrillation Management

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Delayed Cardiac Arrest After On-Pump Transcatheter Valve Trans-septal Mitral Valve-in-Valve Replacement Combined With Alcohol Septal Ablation to Relieve Left Ventricular Outflow Tract Obstruction: A Cautionary Tale

Mitraclip in Systolic Anterior Motion in Patient Not Suitable for Septal Myectomy or Alcohol Ablation

Advances in Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

Results From The BRAVO 3 Randomized Trial

Cases: The Good, The Bad and The Ugly

Thromboembolic Prophylaxis in Atrial Fibrillation

Apixaban in Patients With Atrial Fibrillation After TAVR

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content